- Synonyms(Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxy-5-phenylpent-1-en-1-yl)cyclopentyl)-N-ethylhept-5-enamide-D5; (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-(ethyl-d5)-5-heptenamide; AGN-192024-d5; Lumigan-d5; Prostamide-d5
- Description
(Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxy-5-phenylpent-1-en-1-yl)cyclopentyl)-N-ethylhept-5-enamide-D5; (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-(ethyl-d5)-5-heptenamide; AGN-192024-d5; Lumigan-d5; Prostamide-d5
Bimatoprost-d5 is a fully characterized chemical compound used as a reference standard of API Bimatoprost. The standard offered is compliant with regulatory guidelines. Bimatoprost-d5 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 155206-00-1-unlabelled
Related products
(5-(ethylamino)-5-oxopentyl)triphenylphosphonium bromide

M.F.
M.W. 390.49 79.90
CAT# AR-B01642
CAS# 1201226-16-5